The liver in times of COVID-19: What hepatologists should know

by Ezequiel Ridruejo, Alejandro Soza
Published 2020-07-01

Shortened therapy for genotype 1 hepatitis C virus. The final answer?

by Francisco Barrera M, Alejandro Soza
Published 2010-01-01

Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications

by Marco Arrese, Arnoldo Riquelme, Alejandro Soza
Published 2010-01-01

Routes of transmission of hepatitis C virus

by Alejandro Soza, Arnoldo Riquelme, Marco Arrese
Published 2010-01-01

Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in Chile.

by Constanza L Vargas, Manuel A Espinoza, Andrés Giglio, Alejandro Soza
Published 2015-01-01

Effect of ezetimibe in HCV viral load after liver transplantation

by Hugo Monrroy-Bravo, Jennifer Angulo, Karla Pino, Pilar Labbé, Marcelo López-Lastra, Alejandro Soza
Published 2016-09-01

Portal hypertension and acute liver failure as uncommon manifestations of primary amyloidosis

by Blanca Norero, Rosa María Pérez-Ayuso, Ignacio Duarte, Pablo Ramirez, Alejandro Soza, Marco Arrese, Carlos Benítez
Published 2014-01-01

Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients

by Francisco Barrera, Arnoldo Riquelme, Alejandro Soza, Álvaro Contreras, Gerty Barrios, Oslando Padilla, Paola Viviani, Rosa María Pérez-Ayuso
Published 2009-10-01

Influence of extrahepatic viral infection on the natural history of hepatitis C

by María Inés Barría, Jorge Vera-Otarola, Úrsula León, Valeska Vollrath, Delphine Marsac, Arnoldo Riquelme, Marcelo López-Lastra, Alejandro Soza
Published 2008-04-01

Operational tolerance after liver transplantation, more common than we think: A case report(◆)(◆)This paper was partially funded by the FONDECYT project No. 11100113.

by Carlos Benítez, MD, Juan Pablo Arancibia, Marco Arrese, Alejandro Soza, Pilar Domínguez, Nicolás Jarufe, Jorge Martínez, Rosa María Pérez-Ayuso
Published 2011-07-01

Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C

by Alejandro Soza, Marco Arrese, Robinson González, Manuel Alvarez, Rosa María Pérez, Pablo Cortés, Alejandro Patillo, Arnoldo Riquelme, Juan Carlos Glasinovic
Published 2004-10-01

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin

by Alejandro Soza, M.D., Pilar Labbé, Marco Arrese, Arnoldo Riquelme, Francisco Barrera, Carlos Benítez, Alvaro Huete, M. Elvira Balcells, Jaime Labarca
Published 2015-01-01

Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis

by Paula Vial, Arnoldo Riquelme, Margarita Pizarro, Nancy Solís, Juan Andrés Madariaga, Gloria Aguayo, Ignacio Duarte, Alejandro Soza, Luigi Accatino, Marco Arrese
Published 2006-01-01

Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key

by Blanca Norero, Carolina A. Serrano, Alberto Sanchez-Fueyo, Ignacio Duarte, Javiera Torres, Mauricio Ocquetau, Francisco Barrera, Marco Arrese, Alejandro Soza, Carlos Benítez
Published 2017-01-01

Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients

by Roberto Candia, Blanca Norero, Carlos Agüero, Luis Díaz, Juan Pablo Ortega, Rodrigo Wolff, Cristian Hernández-Rocha, Ignacio Duarte, Alejandro Soza, Carlos Benítez, Marco Arrese
Published 2017-09-01

LDL particle size and antioxidant HDL function improve after sustained virological response in patients with chronic HCV

by Jose Ignacio Vargas, Katherine Rivera, Marco Arrese, Carlos Benitez, Francisco Barrera, Monrroy Hugo, Juan Pablo Arab, Karla Pino, Aldo Barrera, Marcelo Lopez-Lastra, Attilio Rigotti, Alejandro Soza
Published 2022-01-01

Incidence and prevalence of hepatitis C virus infection in Chile

by Robinson González, Alejandro Soza, Verónica Hernández, Rosa M. Pérez, Manuel Álvarez, Arturo Morales, Marco Arellano, Arnoldo Riquelme, Paola Viviani, Carmen Covarrubias, Marco Arrese, Juan Francisco Miquel, Flavio Nervi
Published 2005-04-01

Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study

by Mauricio Gabrielli, Fabrizio Moisan, Marcela Vidal, Ignacio Duarte, Macarena Jiménez, Guillermo Izquierdo, Pilar Domínguez, Javier Méndez, Alejandro Soza, Carlos Benitez, Rosa Pérez, Marco Arrese, Juan Guerra, Nicolás Jarufe, Jorge Martínez, M.D.
Published 2012-11-01

Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study

by Federico Pinero, Paulo Costa, Yuri L. Boteon, Sergio Hoyos Duque, Sebastian Marciano, Margarita Anders, Adriana Varón, Alina Zerega, Jaime Poniachik, Alejandro Soza, Martín Padilla Machaca, Josemaría Menéndez, Rodrigo Zapata, Mario Vilatoba, Linda Muñoz, Martín Maraschio, Martín Fauda, Lucas McCormack, Adrian Gadano, Ilka SF Boin, Jose H. Parente García, Marcelo Silva
Published 2018-03-01

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

by Norberto C. Chávez-Tapia, Ezequiel Ridruejo, Angelo Alves de Mattos, Fernando Bessone, Jorge Daruich, Juan F. Sánchez-Ávila, Hugo Cheinquer, Rodrigo Zapata, Misael Uribe, Francisco Bosques-Padilla, Adrián Gadano, Alejandro Soza, Milagros Dávalos-Moscol, Claudio Marroni, Linda Muñoz-Espinoza, Graciela Castro-Narro, Raymundo Paraná, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Published 2013-03-01